702 Results

People

  1. Motzer
    Motzer
  2. Livingston
    Livingston
  3. Norton
    Norton
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Krown
    Krown
  7. Sepkowitz
    Sepkowitz
  8. O'Reilly
    O'Reilly
  9. Panageas
    Panageas
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)
  7. Epidemiology and Biostatistics (73)
  8. GSK Faculty (73)
  9. Division of Subspecialty Medicine (65)
  10. Gastrointestinal Oncology Service (64)
  1. "fever"
Formats
  1. Journal Article (657)
  2. Review (23)
  3. Conference Paper (6)
  4. Research Letter (6)
  5. Guidelines (5)
  6. Editorial (4)
  7. Correspondence (1)
Groups
  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)

More Groups

People
  1. Robert Motzer (24)
  2. Larry Norton (20)
  3. Philip Livingston (19)
  4. Carol Aghajanian (17)
  5. Clifford Hudis (17)
  6. Kent Sepkowitz (17)

More People

Years
  1. 2025 (21)
  2. 2024 (42)
  3. 2023 (40)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (44)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Clinical Cancer Research (33)
  3. Blood (22)
  4. Lancet Oncology (22)
  5. Cancer (21)
  6. New England Journal of Medicine (18)

More Publications

Publishers
  1. Elsevier Inc. (107)
  2. American Society of Clinical Oncology (70)
  3. Elsevier Science, Inc. (55)
  4. Springer (53)
  5. Nature Publishing Group (40)
  6. Wiley Blackwell (38)

More Publishers

Results (702)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
    Journal Article

    Magro, C.; Mulvey, J. J.; Berlin, D.; Nuovo, G.; Salvatore, S.; Harp, J.; Baxter-Stoltzfus, A.; Laurence, J.
    Translational Research (2020)

    Fulltext@MSK | Save
  • Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
    Research Letter

    Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S.; O’Connor, O. A.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Need for caution in the diagnosis of radiation pneumonitis during the COVID-19 pandemic
    Research Letter

    Shaverdian, N.; Shepherd, A. F.; Rimner, A.; Wu, A. J.; Simone, C. B. 2nd; Gelblum, D. Y.; Gomez, D. R.
    Advances in Radiation Oncology (2020)

    Fulltext@MSK | Save
  • Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
    Journal Article

    Laurence, J.; Mulvey, J. J.; Seshadri, M.; Racanelli, A.; Harp, J.; Schenck, E. J.; Zappetti, D.; Horn, E. M.; Magro, C. M.
    Clinical Immunology (2020)

    Fulltext@MSK | Save
  • Emergency room imaging in patients with genitourinary cancers: Analysis of the spectrum of CT findings and their relation to patient outcomes
    Journal Article

    Woo, S.; Bou Ayache, J.; Sawan, P.; Infantino, J.; Gangai, N.; Wibmer, A.; Hricak, H.; Groeger, J. S.; Vargas, H. A.
    Emergency Radiology (2020)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    Research Letter

    Nawar, T.; Morjaria, S.; Kaltsas, A.; Patel, D.; Perez-Johnston, R.; Daniyan, A. F.; Mailankody, S.; Parameswaran, R.
    American Journal of Hematology (2020)

    Fulltext@MSK | Save
  • BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
    Journal Article

    Stanchina, M.; McKinnell, Z.; Park, J. H.; Stein, E. M.; Cai, S. F.; Taylor, J.
    Leukemia Research Reports (2020)

    Fulltext@MSK | Save
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
    Journal Article

    Goldberg, A. D.; Atallah, E.; Rizzieri, D.; Walter, R. B.; Chung, K. Y.; Spira, A.; Stock, W.; Tallman, M. S.; Cruz, H. G.; Boni, J.; more...
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: A multicentre, open-label, phase 1 study
    Journal Article

    Tan, D. S. W.; Leighl, N. B.; Riely, G. J.; Yang, J. C. H.; Sequist, L. V.; Wolf, J.; Seto, T.; Felip, E.; Aix, S. P.; Jonnaert, M.; more...
    The Lancet Respiratory Medicine (2020)

    Fulltext@MSK | Save